APO Research
Talk to an analyst

APO RESEARCH · REPORT

Donepezil Generic Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Donepezil Generic Drug Industry Growth and Trends Forecast to 2032

29 December 2025105 pages

Choose your research edition.

Industry ResearchDonepezil Generic Drug Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Donepezil Generic Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Donepezil Generic Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Donepezil Generic Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Donepezil Generic Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Donepezil Generic Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Donepezil Generic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Donepezil Generic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Donepezil Generic Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Donepezil Generic Drug include Teva, Sun Pharmaceutical, Novartis, Pfizer, Luoxin, Jishengtang Pharma, Hansoh Pharma, Dr Reddy's Laboratories and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Donepezil Generic Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Donepezil Generic Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Donepezil Generic Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Donepezil Generic Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Donepezil Generic Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Donepezil Generic Drug Market by Company

Teva

Sun Pharmaceutical

Novartis

Pfizer

Luoxin

Jishengtang Pharma

Hansoh Pharma

Dr Reddy's Laboratories

Cipla

ARK PHA.LTD

Apotex

Donepezil Generic Drug Segment by Type

10mg

23mg

5mg

Donepezil Generic Drug Segment by Application

Hospitals

Clinics

Drugstore

Donepezil Generic Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil Generic Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Donepezil Generic Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil Generic Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Donepezil Generic Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Donepezil Generic Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 10mg Table 2. Major Company of 23mg Table 3. Major Company of 5mg Table 4. Global Donepezil Generic Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Donepezil Generic Drug Sales by Type (2021-2026) & (K Units) Table 6. Global Donepezil Generic Drug Sales Market Share in Volume by Type (2021-2026) Table 7. Global Donepezil Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 8. Global Donepezil Generic Drug Sales Market Share in Value by Type (2021-2026) Table 9. Global Donepezil Generic Drug Price by Type (2021-2026) & (US$/Unit) Table 10. Global Donepezil Generic Drug Sales by Type (2027-2032) & (K Units) Table 11. Global Donepezil Generic Drug Sales Market Share in Volume by Type (2027-2032) Table 12. Global Donepezil Generic Drug Sales by Type (2027-2032) & (US$ Million) Table 13. Global Donepezil Generic Drug Sales Market Share in Value by Type (2027-2032) Table 14. Global Donepezil Generic Drug Price by Type (2027-2032) & (US$/Unit) Table 15. North America Donepezil Generic Drug Sales by Type (2021-2026) & (K Units) Table 16. North America Donepezil Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Donepezil Generic Drug Sales by Type (2021-2026) & (K Units) Table 18. Europe Donepezil Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Donepezil Generic Drug Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Donepezil Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Donepezil Generic Drug Sales by Type (2021-2026) & (K Units) Table 22. Latin America Donepezil Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Donepezil Generic Drug Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Donepezil Generic Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Donepezil Generic Drug Industry Trends Table 26. Donepezil Generic Drug Industry Drivers Table 27. Donepezil Generic Drug Industry Opportunities and Challenges Table 28. Donepezil Generic Drug Industry Restraints Table 29. Global Donepezil Generic Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Donepezil Generic Drug Revenue Market Share by Company (2021-2026) Table 31. Global Donepezil Generic Drug Sales by Company (2021-2026) & (K Units) Table 32. Global Donepezil Generic Drug Sales Share by Company (2021-2026) Table 33. Global Donepezil Generic Drug Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Donepezil Generic Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Donepezil Generic Drug Major Company Production Sites and Headquarters Table 36. Global Donepezil Generic Drug Company, Product Type & Application Table 37. Global Donepezil Generic Drug Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Donepezil Generic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Donepezil Generic Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Donepezil Generic Drug Sales by Region (2021-2026) & (K Units) Table 42. Global Donepezil Generic Drug Sales Market Share in Volume by Region (2021-2026) Table 43. Global Donepezil Generic Drug Sales by Region (2021-2026) & (US$ Million) Table 44. Global Donepezil Generic Drug Sales Market Share in Value by Region (2021-2026) Table 45. Global Donepezil Generic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Donepezil Generic Drug Sales by Region (2027-2032) & (K Units) Table 47. Global Donepezil Generic Drug Sales Market Share in Volume by Region (2027-2032) Table 48. Global Donepezil Generic Drug Sales by Region (2027-2032) & (US$ Million) Table 49. Global Donepezil Generic Drug Sales Market Share in Value by Region (2027-2032) Table 50. Global Donepezil Generic Drug Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Donepezil Generic Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Donepezil Generic Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Donepezil Generic Drug Sales Market Share in Volume by Application (2021-2026) Table 54. Global Donepezil Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 55. Global Donepezil Generic Drug Sales Market Share in Value by Application (2021-2026) Table 56. Global Donepezil Generic Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Donepezil Generic Drug Sales by Application (2027-2032) & (K Units) Table 58. Global Donepezil Generic Drug Sales Market Share in Volume by Application (2027-2032) Table 59. Global Donepezil Generic Drug Sales by Application (2027-2032) & (US$ Million) Table 60. Global Donepezil Generic Drug Sales Market Share in Value by Application (2027-2032) Table 61. Global Donepezil Generic Drug Price by Application (2027-2032) & (US$/Unit) Table 62. North America Donepezil Generic Drug Sales by Application (2021-2026) & (K Units) Table 63. North America Donepezil Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Donepezil Generic Drug Sales by Application (2021-2026) & (K Units) Table 65. Europe Donepezil Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Donepezil Generic Drug Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Donepezil Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Donepezil Generic Drug Sales by Application (2021-2026) & (K Units) Table 69. Latin America Donepezil Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Donepezil Generic Drug Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Donepezil Generic Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Teva Company Information Table 73. Teva Business Overview Table 74. Teva Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Teva Donepezil Generic Drug Product Portfolio Table 76. Teva Recent Development Table 77. Sun Pharmaceutical Company Information Table 78. Sun Pharmaceutical Business Overview Table 79. Sun Pharmaceutical Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Sun Pharmaceutical Donepezil Generic Drug Product Portfolio Table 81. Sun Pharmaceutical Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Novartis Donepezil Generic Drug Product Portfolio Table 86. Novartis Recent Development Table 87. Pfizer Company Information Table 88. Pfizer Business Overview Table 89. Pfizer Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Donepezil Generic Drug Product Portfolio Table 91. Pfizer Recent Development Table 92. Luoxin Company Information Table 93. Luoxin Business Overview Table 94. Luoxin Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Luoxin Donepezil Generic Drug Product Portfolio Table 96. Luoxin Recent Development Table 97. Jishengtang Pharma Company Information Table 98. Jishengtang Pharma Business Overview Table 99. Jishengtang Pharma Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Jishengtang Pharma Donepezil Generic Drug Product Portfolio Table 101. Jishengtang Pharma Recent Development Table 102. Hansoh Pharma Company Information Table 103. Hansoh Pharma Business Overview Table 104. Hansoh Pharma Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Hansoh Pharma Donepezil Generic Drug Product Portfolio Table 106. Hansoh Pharma Recent Development Table 107. Dr Reddy's Laboratories Company Information Table 108. Dr Reddy's Laboratories Business Overview Table 109. Dr Reddy's Laboratories Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Dr Reddy's Laboratories Donepezil Generic Drug Product Portfolio Table 111. Dr Reddy's Laboratories Recent Development Table 112. Cipla Company Information Table 113. Cipla Business Overview Table 114. Cipla Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Cipla Donepezil Generic Drug Product Portfolio Table 116. Cipla Recent Development Table 117. ARK PHA.LTD Company Information Table 118. ARK PHA.LTD Business Overview Table 119. ARK PHA.LTD Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. ARK PHA.LTD Donepezil Generic Drug Product Portfolio Table 121. ARK PHA.LTD Recent Development Table 122. Apotex Company Information Table 123. Apotex Business Overview Table 124. Apotex Donepezil Generic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Apotex Donepezil Generic Drug Product Portfolio Table 126. Apotex Recent Development Table 127. North America Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. North America Donepezil Generic Drug Sales by Country (2021-2026) & (K Units) Table 129. North America Donepezil Generic Drug Sales Market Share by Country (2021-2026) Table 130. North America Donepezil Generic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 131. North America Donepezil Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 132. North America Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Donepezil Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Donepezil Generic Drug Market Share by Country (2021-2026) Table 135. North America Donepezil Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Donepezil Generic Drug Market Share Forecast by Country (2027-2032) Table 137. Europe Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Europe Donepezil Generic Drug Sales by Country (2021-2026) & (K Units) Table 139. Europe Donepezil Generic Drug Sales Market Share by Country (2021-2026) Table 140. Europe Donepezil Generic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 141. Europe Donepezil Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Donepezil Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Donepezil Generic Drug Market Share by Country (2021-2026) Table 145. Europe Donepezil Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Donepezil Generic Drug Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Donepezil Generic Drug Sales by Country (2021-2026) & (K Units) Table 149. Asia-Pacific Donepezil Generic Drug Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Donepezil Generic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 151. Asia-Pacific Donepezil Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Donepezil Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Donepezil Generic Drug Market Share by Country (2021-2026) Table 155. Asia-Pacific Donepezil Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Donepezil Generic Drug Market Share Forecast by Country (2027-2032) Table 157. Latin America Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Latin America Donepezil Generic Drug Sales by Country (2021-2026) & (K Units) Table 159. Latin America Donepezil Generic Drug Sales Market Share by Country (2021-2026) Table 160. Latin America Donepezil Generic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 161. Latin America Donepezil Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Donepezil Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Donepezil Generic Drug Market Share by Country (2021-2026) Table 165. Latin America Donepezil Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Donepezil Generic Drug Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Donepezil Generic Drug Sales by Country (2021-2026) & (K Units) Table 169. Middle East and Africa Donepezil Generic Drug Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Donepezil Generic Drug Sales Forecast by Country (2027-2032) & (K Units) Table 171. Middle East and Africa Donepezil Generic Drug Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Donepezil Generic Drug Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Donepezil Generic Drug Market Share by Country (2021-2026) Table 175. Middle East and Africa Donepezil Generic Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Donepezil Generic Drug Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Donepezil Generic Drug Distributors List Table 180. Donepezil Generic Drug Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Donepezil Generic Drug Image Figure 2. Global Donepezil Generic Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Donepezil Generic Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Donepezil Generic Drug Sales (2021-2032) & (K Units) Figure 5. 10mg Image Figure 6. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 23mg Image Figure 8. Global 23mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. 5mg Image Figure 10. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Donepezil Generic Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Donepezil Generic Drug Market Share by Type 2025 VS 2032 Figure 13. North America Donepezil Generic Drug Sales Market Share in Volume by Type in 2025 Figure 14. North America Donepezil Generic Drug Sales Market Share in Value by Type in 2025 Figure 15. Europe Donepezil Generic Drug Sales Market Share in Volume by Type in 2025 Figure 16. Europe Donepezil Generic Drug Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Donepezil Generic Drug Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Donepezil Generic Drug Sales Market Share in Value by Type in 2025 Figure 19. Latin America Donepezil Generic Drug Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Donepezil Generic Drug Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Donepezil Generic Drug Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Donepezil Generic Drug Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Donepezil Generic Drug Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinics Image Figure 28. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Drugstore Image Figure 30. Global Drugstore Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Donepezil Generic Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Donepezil Generic Drug Market Share by Application 2025 VS 2032 Figure 33. North America Donepezil Generic Drug Sales Market Share in Volume by Application in 2025 Figure 34. North America Donepezil Generic Drug Sales Market Share in Value by Application in 2025 Figure 35. Europe Donepezil Generic Drug Sales Market Share in Volume by Application in 2025 Figure 36. Europe Donepezil Generic Drug Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Donepezil Generic Drug Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Donepezil Generic Drug Sales Market Share in Value by Application in 2025 Figure 39. Latin America Donepezil Generic Drug Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Donepezil Generic Drug Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Donepezil Generic Drug Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Donepezil Generic Drug Sales Market Share in Value by Application in 2025 Figure 43. North America Donepezil Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Donepezil Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Donepezil Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Donepezil Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Donepezil Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Donepezil Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Donepezil Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Donepezil Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Donepezil Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Donepezil Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Donepezil Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Donepezil Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Donepezil Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Donepezil Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Donepezil Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Donepezil Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Donepezil Generic Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Donepezil Generic Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Donepezil Generic Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Donepezil Generic Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Donepezil Generic Drug Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Donepezil Generic Drug Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 23mg
  • 5mg
Applications
  • Hospitals
  • Clinics
  • Drugstore
Companies covered
  • Teva
  • Sun Pharmaceutical
  • Novartis
  • Pfizer
  • Luoxin
  • Jishengtang Pharma
  • Hansoh Pharma
  • Dr Reddy's Laboratories
  • Cipla
  • ARK PHA.LTD
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Donepezil Generic Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Donepezil Generic Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Donepezil Generic Drug Market by Type
  6. 1.3.1 10mg
  7. 1.3.2 23mg
  8. 1.3.3 5mg
  9. 1.4 Global Donepezil Generic Drug Market Size by Type
  10. 1.4.1 Global Donepezil Generic Drug Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Donepezil Generic Drug Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Donepezil Generic Drug Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Donepezil Generic Drug Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Donepezil Generic Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Donepezil Generic Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Donepezil Generic Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Donepezil Generic Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Donepezil Generic Drug Industry Trends
  2. 2.2 Donepezil Generic Drug Industry Drivers
  3. 2.3 Donepezil Generic Drug Industry Opportunities and Challenges
  4. 2.4 Donepezil Generic Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Donepezil Generic Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Donepezil Generic Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Donepezil Generic Drug Price (2021-2026)
  4. 3.4 Global Donepezil Generic Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Donepezil Generic Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Donepezil Generic Drug Company, Product Type & Application
  7. 3.7 Global Donepezil Generic Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Donepezil Generic Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Donepezil Generic Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Donepezil Generic Drug Tier 1, Tier 2, and Tier 3
4 Donepezil Generic Drug Regional Status and Outlook
  1. 4.1 Global Donepezil Generic Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Donepezil Generic Drug Historic Market Size by Region
  3. 4.2.1 Global Donepezil Generic Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Donepezil Generic Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Donepezil Generic Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Donepezil Generic Drug Forecasted Market Size by Region
  7. 4.3.1 Global Donepezil Generic Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Donepezil Generic Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Donepezil Generic Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Donepezil Generic Drug by Application
  1. 5.1 Donepezil Generic Drug Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Drugstore
  5. 5.2 Global Donepezil Generic Drug Market Size by Application
  6. 5.2.1 Global Donepezil Generic Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Donepezil Generic Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Donepezil Generic Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Donepezil Generic Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Donepezil Generic Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Donepezil Generic Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Donepezil Generic Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Donepezil Generic Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Donepezil Generic Drug Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Sun Pharmaceutical
  8. 6.2.1 Sun Pharmaceutical Company Information
  9. 6.2.2 Sun Pharmaceutical Business Overview
  10. 6.2.3 Sun Pharmaceutical Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Donepezil Generic Drug Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Donepezil Generic Drug Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Donepezil Generic Drug Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Luoxin
  26. 6.5.1 Luoxin Company Information
  27. 6.5.2 Luoxin Business Overview
  28. 6.5.3 Luoxin Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Luoxin Donepezil Generic Drug Product Portfolio
  30. 6.5.5 Luoxin Recent Developments
  31. 6.6 Jishengtang Pharma
  32. 6.6.1 Jishengtang Pharma Company Information
  33. 6.6.2 Jishengtang Pharma Business Overview
  34. 6.6.3 Jishengtang Pharma Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jishengtang Pharma Donepezil Generic Drug Product Portfolio
  36. 6.6.5 Jishengtang Pharma Recent Developments
  37. 6.7 Hansoh Pharma
  38. 6.7.1 Hansoh Pharma Company Information
  39. 6.7.2 Hansoh Pharma Business Overview
  40. 6.7.3 Hansoh Pharma Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hansoh Pharma Donepezil Generic Drug Product Portfolio
  42. 6.7.5 Hansoh Pharma Recent Developments
  43. 6.8 Dr Reddy's Laboratories
  44. 6.8.1 Dr Reddy's Laboratories Company Information
  45. 6.8.2 Dr Reddy's Laboratories Business Overview
  46. 6.8.3 Dr Reddy's Laboratories Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Dr Reddy's Laboratories Donepezil Generic Drug Product Portfolio
  48. 6.8.5 Dr Reddy's Laboratories Recent Developments
  49. 6.9 Cipla
  50. 6.9.1 Cipla Company Information
  51. 6.9.2 Cipla Business Overview
  52. 6.9.3 Cipla Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Cipla Donepezil Generic Drug Product Portfolio
  54. 6.9.5 Cipla Recent Developments
  55. 6.10 ARK PHA.LTD
  56. 6.10.1 ARK PHA.LTD Company Information
  57. 6.10.2 ARK PHA.LTD Business Overview
  58. 6.10.3 ARK PHA.LTD Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 ARK PHA.LTD Donepezil Generic Drug Product Portfolio
  60. 6.10.5 ARK PHA.LTD Recent Developments
  61. 6.11 Apotex
  62. 6.11.1 Apotex Company Information
  63. 6.11.2 Apotex Business Overview
  64. 6.11.3 Apotex Donepezil Generic Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Apotex Donepezil Generic Drug Product Portfolio
  66. 6.11.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Donepezil Generic Drug Sales by Country
  2. 7.1.1 North America Donepezil Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Donepezil Generic Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Donepezil Generic Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Donepezil Generic Drug Market Size by Country
  6. 7.2.1 North America Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Donepezil Generic Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Donepezil Generic Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Donepezil Generic Drug Sales by Country
  2. 8.1.1 Europe Donepezil Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Donepezil Generic Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Donepezil Generic Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Donepezil Generic Drug Market Size by Country
  6. 8.2.1 Europe Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Donepezil Generic Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Donepezil Generic Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Donepezil Generic Drug Sales by Country
  2. 9.1.1 Asia-Pacific Donepezil Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Donepezil Generic Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Donepezil Generic Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Donepezil Generic Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Donepezil Generic Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Donepezil Generic Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Donepezil Generic Drug Sales by Country
  2. 10.1.1 South America Donepezil Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Donepezil Generic Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Donepezil Generic Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Donepezil Generic Drug Market Size by Country
  6. 10.2.1 South America Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Donepezil Generic Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Donepezil Generic Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Donepezil Generic Drug Sales by Country
  2. 11.1.1 Middle East and Africa Donepezil Generic Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Donepezil Generic Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Donepezil Generic Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Donepezil Generic Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Donepezil Generic Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Donepezil Generic Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Donepezil Generic Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Donepezil Generic Drug Value Chain Analysis
  2. 12.1.1 Donepezil Generic Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Donepezil Generic Drug Production Mode & Process
  7. 12.2 Donepezil Generic Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Donepezil Generic Drug Distributors
  10. 12.2.3 Donepezil Generic Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst